GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a remarkable innovation in how we handle type 2 diabetes . These injectable therapies function to imitating the body’s own GLP-1 https://cruxbookmarks.com/story21821905/glp-1-a-significant-advance-in-blood-sugar-care